ArticleBMC nephrology2020
Machine learning algorithm for early detection of end-stage renal disease.
Article in BMC nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Predict, diagnose, and treat chronic kidney disease with machine learning: a systematic literature review.Journal of nephrology · 2023Pooled it
- Applications of Machine Learning for Early Diagnosis and Prognosis of Chronic Kidney Disease: Current Evidence.Diagnostics (Basel, Switzerland) · 2026Review
- Predicting Chronic Kidney Disease from Biomarkers: An Explainable Machine Learning Approach.Diagnostics (Basel, Switzerland) · 2026Article
- AI-Assisted Decision-Making for End-Stage Organ Failure: Opportunities and Ethical Concerns.Artificial organs · 2026Review
- An intelligent ensemble machine learning model for early detection of chronic kidney disease in aging populations.Scientific reports · 2026Article
- Stacking ensemble model for predicting chronic kidney disease in the Uddanam region of India with unknown etiology.Scientific reports · 2025Article
- Validation of an Algorithm to Identify End-Stage Kidney Disease in Electronic Health Records Data.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2025Article
- Predicting rapid kidney function decline in middle-aged and elderly Chinese adults using machine learning techniques.BMC medical informatics and decision making · 2025Article
- Ensemble machine learning for predicting renal function decline in chronic kidney disease: development and external validation.Frontiers in medicine · 2025Article
- Cloud-based real-time enhancement for disease prediction using Confluent Cloud, Apache Kafka, feature optimization, and explainable artificial intelligence.PeerJ. Computer science · 2025Article
- Variational quantum classifier-based early identification and classification of chronic kidney disease using sparse autoencoder and LASSO shrinkage.PeerJ. Computer science · 2025Article
- A new era in the science and care of kidney diseases.Nature reviews. Nephrology · 2024Review
- A Klotho-Based Machine Learning Model for Prediction of both Kidney and Cardiovascular Outcomes in Chronic Kidney Disease.Kidney diseases (Basel, Switzerland) · 2024Article
- Review
- Early prediction of end-stage kidney disease using electronic health record data: a machine learning approach with a 2-year horizon.JAMIA open · 2024Article
- Development and validation of a machine learning model to predict time to renal replacement therapy in patients with chronic kidney disease.BMC nephrology · 2024Article
- An Approach for Personalized Dynamic Assessment of Chronic Kidney Disease Progression Using Joint Model.Biomedicines · 2024Article
- Investigation on explainable machine learning models to predict chronic kidney diseases.Scientific reports · 2024Article
- SGLT2 Inhibitor Use and Risk of Breast Cancer Among Adult Women with Type 2 Diabetes.Drug safety · 2024Article
- Predicting CKD progression using time-series clustering and light gradient boosting machines.Scientific reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundEnd stage renal disease (ESRD) describes the most severe stage of chronic kidney disease (CKD), when patients need dialysis or renal transplant. There is often a delay in recognizing, diagnosing, and treating the various etiologies of CKD. The objective of the present study was to employ machine learning algorithms to develop a prediction model for progression to ESRD based on a large-scale multidimensional database.
methodsThis study analyzed 10,000,000 medical insurance claims from 550,000 patient records using a commercial health insurance database. Inclusion criteria were patients over the age of 18 diagnosed with CKD Stages 1-4. We compiled 240 predictor candidates, divided into six feature groups: demographics, chronic conditions, diagnosis and procedure features, medication features, medical costs, and episode counts. We used a feature embedding method based on implementation of the Word2Vec algorithm to further capture temporal information for the three main components of the data: diagnosis, procedures, and medications. For the analysis, we used the gradient boosting tree algorithm (XGBoost implementation).
resultsThe C-statistic for the model was 0.93 [(0.916-0.943) 95% confidence interval], with a sensitivity of 0.715 and specificity of 0.958. Positive Predictive Value (PPV) was 0.517, and Negative Predictive Value (NPV) was 0.981. For the top 1 percentile of patients identified by our model, the PPV was 1.0. In addition, for the top 5 percentile of patients identified by our model, the PPV was 0.71. All the results above were tested on the test data only, and the threshold used to obtain these results was 0.1. Notable features contributing to the model were chronic heart and ischemic heart disease as a comorbidity, patient age, and number of hypertensive crisis events.
conclusionsWhen a patient is approaching the threshold of ESRD risk, a warning message can be sent electronically to the physician, who will initiate a referral for a nephrology consultation to ensure an investigation to hasten the establishment of a diagnosis and initiate management and therapy when appropriate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.